A new wave of state requirements takes effect in 2027. Different states, different bills, but a shared direction: more transparency, more human clinical oversight, stronger patient access protections, and greater accountability in prior authorization and adverse determination workflows.
Join MRIoA’s Fall 2026 Regulatory Roundtable for a practical look at what’s coming and how to assess whether your organization is ready. The session is built for compliance, clinical, operational, and utilization management leaders who need to turn regulatory change into operational decisions.
Wednesday, Oct. 7 | 1 p.m. EDT
Register here →
What You’ll Gain:
- A clear view of the 2027 implementation landscape and the common themes running through this year’s state legislation
- How new requirements may affect review standards, AI-supported review, prior authorization reporting and publication obligations, and electronic prior authorization readiness
- Practical considerations for assessing policy, process, delegation, technology, and documentation readiness
States on the Radar:
Alaska, Colorado, Delaware, Georgia, Illinois, Iowa, Kentucky, Louisiana, Minnesota, New Hampshire, New Mexico, New York, Oregon, Virginia, and Washington, with California still under watch.
Why It Matters:
State requirements rarely arrive all at once, and they rarely line up neatly. Plans operating across multiple states will need to reconcile different definitions, timelines, and reporting obligations inside the same workflows. Organizations that start assessing readiness in 2026 have room to adjust policies, retrain teams, and validate documentation before the requirements take effect. Organizations that wait will be doing the same work against a deadline.
Led by Aja Leichliter, Vice President and Chief Compliance Officer at MRIoA, this session draws on more than 20 years of experience across state utilization review and independent review organization mandates, URAC and NCQA standards, and federal prior authorization rules.
